Showing 40,261 - 40,280 results of 128,945 for search '(( i e decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.25s Refine Results
  1. 40261

    Table1_Changes in the global burden of foreign body aspiration among under-5 children from 1990 to 2019.xls by Yuying Wu (647826)

    Published 2023
    “…Compared to 1990, although a decrease in both incidence and DALYs occurred in 2019, the Joinpoint regression showed an increasing trend in incidence rate from 2014 to 2019 [APC: both (2.10), female (2.25), male (1.98), P < 0.05)], especially China, Netherlands, and Malta. …”
  2. 40262

    Image1_Changes in the global burden of foreign body aspiration among under-5 children from 1990 to 2019.pdf by Yuying Wu (647826)

    Published 2023
    “…Compared to 1990, although a decrease in both incidence and DALYs occurred in 2019, the Joinpoint regression showed an increasing trend in incidence rate from 2014 to 2019 [APC: both (2.10), female (2.25), male (1.98), P < 0.05)], especially China, Netherlands, and Malta. …”
  3. 40263
  4. 40264
  5. 40265

    <i>Krüppel</i>-like factor 5 activates chick intestinal stem cell and promotes mucosal repair after impairment by Lingzi Yu (17376450)

    Published 2023
    “…Strikingly, upon LPS challenge, increased mRNA transcriptional level of <i>Krüppel</i>-like factor 5 (<i>Klf5</i>) was detected in the crypt. Moreover, under LPS treatment in organoids, the KLF5 inhibitor (ML264) would decrease the mRNA and protein levels of Stat5a and Hopx, the STAT5A inhibitor (AC-4-130) would suppress the <i>Lgr5</i> mRNA and protein levels. …”
  6. 40266

    Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men by Christa Broholm (155817)

    Published 2020
    “…</p> <p>After correcting for multiple comparisons (q ≤ 0.05), 56 CpG sites were found to be significantly, differentially methylated in myoblasts from LBW compared with NBW men, of which the top five gene-annotated CpG sites (<i>SKI, ARMCX3, NR5A2, NEUROG, ESRRG</i>) previously have been associated to regulation of cholesterol, fatty acid and glucose metabolism and muscle development or hypertrophy. …”
  7. 40267

    Different vascular density in humeri of adult <i>Nothosaurus</i> and <i>Cymatosaurus</i> (histotype A). by Nicole Klein (164099)

    Published 2010
    “…Note in D) also the high number of flat osteocytes in the nearly avascular tissue. E–F) Samples of <i>Nothosaurus</i> morphotype II humeri in normal light. …”
  8. 40268

    Dataset on the Chemical Modification of Ascorbic Acid (AA) to L-ascorbyl-6-palmitate (AP): A Novel Approach For Improved Antioxidant Therapy in Traumatic Brain Injury (TBI) by Umar Faruk Saidu (16446285)

    Published 2024
    “…The Means were computed from five replicates (n = 5) for each parameter. A statistical test, ANOVA was used to determine noteworthy differences between the means. …”
  9. 40269

    DataSheet_1_HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility.docx by Mohammed Y. Behairy (12194234)

    Published 2022
    “…Background<p>A deep understanding of the causes of liability to SARS-CoV-2 is essential to develop new diagnostic tests and therapeutics against this serious virus in order to overcome this pandemic completely. …”
  10. 40270

    DataSheet_1_HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility.docx by Mohammed Y. Behairy (12194234)

    Published 2023
    “…Background<p>A deep understanding of the causes of liability to SARS-CoV-2 is essential to develop new diagnostic tests and therapeutics against this serious virus in order to overcome this pandemic completely. …”
  11. 40271
  12. 40272
  13. 40273
  14. 40274
  15. 40275

    DataSheet1_Case report: A case of Rabson–Mendenhall syndrome: long-term follow-up and therapeutic management with empagliflozin.docx by R. Foglino (18870559)

    Published 2024
    “…</p><p>Results: After 10 months of treatment, empagliflozin therapy led to a clinically meaningful reduction in HbA1c levels, decreasing from 8.5% to 7.1%, along with an improvement in TIR from 47% to 74%. …”
  16. 40276
  17. 40277
  18. 40278

    Table_1_Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.pdf by Francesco Angotzi (14145222)

    Published 2023
    “…<p>The approved combination of Tixagevimab/Cilgavimab has been shown to decrease the rate of symptomatic SARS-CoV-2 infection in patients at increased risk of inadequate response to vaccination. …”
  19. 40279
  20. 40280